Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study
Description
CONCLUSIONS: Triflusal use appears to increase the risk of susceptibility to COVID-19 infection and an even higher risk of hospitalization, whereas the other antiplatelets could be associated with a reduction in the risk of the various outcomes or
